Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZSP1601 in NASH Ib/IIa Trial
CTR20200207Phase 2Completed
- Sponsor
- Zhongsheng Pharma
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zsp1601 in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by Zhongsheng Pharma. Started Feb 2020; status: completed.
02
Drugs
zsp1601
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on CTR20200207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200207.